Gene:
Gene Symbol:
Gene Name:
Original Clone ID:
None
Keyword:
Codon optimized
Species:
Homo sapiens
Type:
cDNA
Vector Name:
pDONR221
Format:
FUSION
Source:
None
Description:
None
Comments:
Gene synthesis by Gen9. Codon optimized
Mutation / Discrepancy:
Yes / No
Publications:
None
Authors:
Center for Personalized Diagnostics
HsCD00744813
Price:
Login for Pricing
AVAILABLE
No restriction
Special MTA: None
Special MTA: None
Insert sequence: 2316nts
Open reading frame: 1 to 2316
ATGGGGGACGAGGACGACGATGAGAGTTGCGCCGTGGAGCTGCGGATCACAGAAGCCAAC
CTGACCGGGCACGAGGAGAAGGTGAGCGTGGAGAACTTCGAGCTGCTCAAGGTGCTGGGC
ACGGGAGCCTACGGCAAGGTGTTCCTTGTGCGGAAGGCGGGAGGGCACGACGCGGGAAAG
CTTTACGCCATGAAGGTGCTGCGCAAGGCTGCTCTTGTGCAGCGCGCCAAAACGCAAGAG
CACACACGCACCGAGCGCTCGGTTCTGGAGCTGGTGCGCCAGGCTCCCTTCTTGGTCACC
CTGCACTACGCTTTCCAGACGGATGCCAAGCTGCACCTCATCCTGGACTATGTGAGCGGC
GGGGAGATGTTCACCCACCTCTACCAGCGCCAGTACTTCAAGGAGGCTGAGGTGCGCGTG
TATGGGGGTGAGATCGTGCTGGCCCTGGAACATCTGCACAAGCTCGGCATCATTTACCGA
GATCTGAAACTGGAGAATGTGCTGCTGGACTCTGAGGGCCACATTGTCCTCACGGACTTC
GGGCTGAGCAAGGAGTTCCTGACGGAGGAGAAAGAGAGGACCTTCTCCTTCTGTGGCACC
ATCGAGTACATGGCCCCCGAAATCATCCGTAGCAAGACGGGCCATGGCAAGGCTGTGGAC
TGGTGGAGCCTGGGAATCTTGCTCTTCGAGCTTCTGACGGGAGCCTCGCCTTTCACCCTG
GAGGGCGAGAGGAACACGCAGGCTGAGGTGTCTCGACGGATCCTGAAGTGCTCCCCTCCC
TTCCCCCCTAGAATCGGGCCAGTAGCGCAGGACCTGCTGCAGCGGCTGCTTTGTAAGGAT
CCTAAGAAGCGATTGGGCGCGGGGCCTCAGGGGGCACAAGAAGTCCGGAACCATCCCTTC
TTCCAGGGCCTGGATTGGGTGGCTCTGGCTGCCAGGAAGATTCCAGCCCCATTCCGGCCC
CAAATCCGCTCAGAGCTGGATGTGGGCAACTTTGCGGAGGAATTCACTCGGCTGGAGCCT
GTCTACTCACCCCCTGGCAGCCCCCCACCTGGGGACCCCCGAATCTTTCAGGGATACTCC
TTTGTGGCACCCTCCATTCTCTTTGACCACAACAACGCGGTGATGACCGATGGGCTGGAA
GCGCCTGGTGCTGGAGATCGGCCAGGTAGGGCAGCGGTGGCTAGGAGCGCTATGATGCAG
GACTCGCCCTTCTTCCAGCAGTACGAGCTGGACCTTCGGGAGCCTGCGCTTGGACAGGGC
AGCTTTTCTGTGTGTCGACGCTGCCGCCAGCGCCAAAGTGGCCAGGAGTTCGCAGTCAAG
ATCCTCAGTCGAAGGCTGGAGGCGAATACGCAGCGCGAAGTGGCTGCCCTGCGACTGTGC
CAGTCACACCCCAACGTGGTGAATCTGCACGAGGTGCATCACGACCAGCTCCACACGTAC
CTGGTCCTGGAGCTGCTGAGGGGTGGGGAGCTCCTGGAGCACATCCGCAAGAAGCGGCAC
TTCAGCGAATCGGAAGCAAGCCAGATCCTGCGCAGCCTCGTGTCGGCCGTGAGCTTCATG
CATGAGGAGGCGGGCGTTGTGCACCGTGACCTCAAGCCGGAGAATATCCTTTACGCCGAC
GACACGCCCGGGGCTCCGGTGAAAATCATCGACTTCGGGTTCGCGCGGTTAAGGCCTCAG
AGTCCCGGAGTGCCTATGCAGACACCCTGTTTCACGCTGCAGTACGCTGCTCCCGAGCTT
CTGGCGCAGCAGGGCTACGACGAGTCCTGCGACCTCTGGAGTCTGGGCGTCATTCTGTAC
ATGATGCTGTCGGGGCAGGTTCCCTTCCAGGGGGCATCTGGCCAGGGCGGACAGAGCCAA
GCGGCCGAGATCATGTGCAAAATCCGAGAGGGACGCTTCTCCCTTGACGGAGAGGCCTGG
CAGGGTGTATCCGAGGAAGCCAAGGAGCTTGTCCGAGGGCTCCTGACCGTTGACCCTGCC
AAGCGGCTGAAACTTGAGGGACTTCGGGGAAGCTCTTGGCTGCAGGACGGAAGCGCGCGA
TCTTCGCCCCCTCTTAGGACGCCCGACGTTCTCGAATCCTCTGGACCTGCAGTGCGATCG
GGTCTGAACGCAACCTTCATGGCATTCAACCGGGGCAAGCGGGAGGGCTTCTTCCTGAAG
AGCGTGGAGAATGCACCTCTGGCCAAGCGGCGGAAGCAGAAGCTGCGGAGCGCCACCGCT
TCTAGAAGGGGCTCTCCTGCACCAGCCAATCCGGGAAGAGCTCCTGTCGCTTCAAAAGGG
GCCCCTCGCCGAGCTAACGGACCTCTTCCCCCCTCA
Protein sequence predicted based on nucleotide sequence
MGDEDDDESCAVELRITEANLTGHEEKVSVENFELLKVLGTGAYGKVFLVRKAGGHDAGK LYAMKVLRKAALVQRAKTQEHTRTERSVLELVRQAPFLVTLHYAFQTDAKLHLILDYVSG GEMFTHLYQRQYFKEAEVRVYGGEIVLALEHLHKLGIIYRDLKLENVLLDSEGHIVLTDF GLSKEFLTEEKERTFSFCGTIEYMAPEIIRSKTGHGKAVDWWSLGILLFELLTGASPFTL EGERNTQAEVSRRILKCSPPFPPRIGPVAQDLLQRLLCKDPKKRLGAGPQGAQEVRNHPF FQGLDWVALAARKIPAPFRPQIRSELDVGNFAEEFTRLEPVYSPPGSPPPGDPRIFQGYS FVAPSILFDHNNAVMTDGLEAPGAGDRPGRAAVARSAMMQDSPFFQQYELDLREPALGQG SFSVCRRCRQRQSGQEFAVKILSRRLEANTQREVAALRLCQSHPNVVNLHEVHHDQLHTY LVLELLRGGELLEHIRKKRHFSESEASQILRSLVSAVSFMHEEAGVVHRDLKPENILYAD DTPGAPVKIIDFGFARLRPQSPGVPMQTPCFTLQYAAPELLAQQGYDESCDLWSLGVILY MMLSGQVPFQGASGQGGQSQAAEIMCKIREGRFSLDGEAWQGVSEEAKELVRGLLTVDPA KRLKLEGLRGSSWLQDGSARSSPPLRTPDVLESSGPAVRSGLNATFMAFNRGKREGFFLK SVENAPLAKRRKQKLRSATASRRGSPAPANPGRAPVASKGAPRRANGPLPPS
Coding Sequence Details
Insert Sequence Verified?:
Y
Verification Method:
Sequence Verification
Mutations:
None
Discrepancy:
None
5' Linker Sequence:
None
3' Linker Sequence:
None
Recommended Growth Condition:
Distributed in bacterial strain:
DH5-alpha T1 phage resistant
Antibiotic Selection:
Host Type:
bacterial
Marker:
kanamycin
Bacterial Selection Condition:
50ug/mL kanamycin
Growth Condition:
Growth with the single antibiotic in LB at 37 degrees is recommended.
Comments:
Conditions for Gateway-type vectors in recombined (with insert) form and other kanamycin resistant vectors.
Protein Expression Results:
None
Recommended expression in:
Not Applicable
Vector Name:
pDONR221
Synonyms:
''
Description:
Gateway®, donor (entry), recombinational cloning clone, bacterial expression expression with rrnB T2 and rrnB T1 and M13 forward and attP1 and ccdB and CmR and cat_promoter-var002 and attP2 and T7 promoter and M13 reverse and KanR and ori; 50ug/mL of Kanamycin resistance in Pichia;
Comments:
The position of features were determined for the unrecombined (empty) form of the vector, which is described in detail on the Invitrogen website.
Size (bp):
4762
Parent Vector:
None
Properties:
Gateway, bacterial expression, donor (entry), recombinational cloning
Author Name:
Invitrogen
Publications:
None
Vector Map:
Vector Sequence:
Sequence:
Vector Features:
Type
Name
Description
Start
End
CDS
ccdB
CcdB, a bacterial toxin that poisons DNA gyrase
1197
1502
CDS
CmR
confers resistance to chloramphenicol
1847
2506
CDS
KanR
confers resistance to kanamycin in bacteria or G418 (Geneticin) in eukaryotes
3156
3965
Terminator
rrnB T2
transcription terminator T2 from the E. coli rrnB gene
268
295
Terminator
rrnB T1
transcription terminator T1 from the E. coli rrnB gene
387
473
primer_bind
M13 forward
common sequencing primer, one of multiple similar variants
537
553
primer_bind
M13 reverse
common sequencing primer, one of multiple similar variants
3027
3043
promoter
cat_promoter-var002
promoter of the E. coli cat gene encoding chloramphenicol acetyltransferase
2507
2609
promoter
T7 promoter
promoter for bacteriophage T7 RNA polymerase
3004
3022
protein binding site
attP1
recombination site for the Gateway BP reaction
570
801
protein binding site
attP2
recombination site for the Gateway BP reaction
2754
2985
rep_origin
ori
high-copy-number ColE1/pMB1/pBR322/pUC origin of replication
4112
4700
